A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home AIMD Companies Apnex Medical Apnex Medical’s Implantable Device for Treatment of Sleep Apnea
formats

Apnex Medical’s Implantable Device for Treatment of Sleep Apnea

Image Credit: Apnex Medical

MedicalApnex Medical, Inc. is located in St. Paul, MN. It was founded in 2006 and has developed the Hypoglossal Nerve Stimulation System (HGNS® System) for the treatment of obstructive sleep apnea (OSA). The HGNS System has been evaluated in feasibility studies and is now being assessed in an Investigational Device Exemption (IDE) Study (Apnex®Clinical Study).

The Apnex HGNS System is an implantable therapy that is intended to work by activating the muscles in the upper airway to ensure that the airway remains open during sleep. During sleep, the system detects the patient’s breathing and delivers mild stimulation to the hypoglossal nerve, the nerve that controls the muscles of the tongue, to keep the airway open. The stimulation is timed to a patient’s own breathing pattern. The HGNS System is programmed to work only when the patient is asleep, or it can be turned on and off as needed through a handheld controller.

CE Mark announced October 27, 2011

FDA IDE approval announced August 2, 2011

Company website: www.apnexmedical.com

Click here for Apnex Medical’s patents.

Image Credit: Apnex Medical

 

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Apnex Medical’s Implantable Device for Treatment of Sleep Apnea  comments